| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $720.0M | — | -37.6% |
| Cost of Revenue | $648.0M | — | -38.5% |
| Gross Profit | $72.0M | — | -27.3% |
| R&D Expense | $24.0M | — | +14.3% |
| SG&A Expense | $137.0M | — | +315.2% |
| Operating Income | -$159.0M | — | -183.9% |
| Pre-tax Income | -$173.0M | — | -103.5% |
| Income Tax | $100K | — | -50.0% |
| Net Income | -$173.0M | — | -103.5% |
| EPS (Basic) | -$0.18 | — | -50.0% |
| EPS (Diluted) | -$0.18 | — | -50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $999.0M | +3.8% | +78.7% |
| Current Assets | $2.24B | -2.5% | -28.9% |
| Total Assets | $2.35B | -2.4% | -28.3% |
| Current Liabilities | $317.0M | -3.1% | -69.9% |
| Total Liabilities | $1.40B | -0.5% | -47.0% |
| Stockholders' Equity | $954.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$246.0M | — | +11.8% |
| Capital Expenditures | $4.0M | — | +0.0% |
| Investing Cash Flow | -$4.0M | — | -300.0% |
| Financing Cash Flow | $16.0M | — | -92.3% |
| Free Cash Flow | -$250.0M | — | +11.7% |
| +47.9% |